Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Tax Rate (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Tax Rate for 14 consecutive years, with 46.23% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 13200.0% year-over-year to 46.23%, compared with a TTM value of 14293.72% through Dec 2025, up 1438883.0%, and an annual FY2025 reading of 14293.72%, up 1438883.0% over the prior year.
  • Tax Rate was 46.23% for Q4 2025 at Amicus Therapeutics, down from 49.51% in the prior quarter.
  • Across five years, Tax Rate topped out at 14634.26% in Q2 2024 and bottomed at 85.77% in Q4 2024.
  • Average Tax Rate over 5 years is 738.46%, with a median of 3.09% recorded in 2021.
  • The sharpest move saw Tax Rate soared 1464096bps in 2024, then plummeted -1466157bps in 2025.
  • Year by year, Tax Rate stood at 3.71% in 2021, then skyrocketed by 646bps to 20.28% in 2022, then plummeted by -134bps to 6.9% in 2023, then tumbled by -1144bps to 85.77% in 2024, then surged by 154bps to 46.23% in 2025.
  • Business Quant data shows Tax Rate for FOLD at 46.23% in Q4 2025, 49.51% in Q3 2025, and 27.31% in Q2 2025.